PD-L1 has been found to play a tumor-supporting role in enabling the avoidance of immune surveillance when expressed on the tumor cell surface by interfering with programmed death 1 (PD-1), thereby attenuating the function of cytotoxic CD8+ T cells [27,28]. Here, CD274 is linked to neoplasm.